Matrix Metalloproteinases and Stress Hormones in Lung Cancer Progression

Table 1

Lung adenocarcinoma patients’ clinical characteristics.

Characteristics	All patients	W	N	TS	PS	TW
Subjects	104	36.5 (38/104)	25 (26/104)	21.2 (22/104)	9.6 (10/104)	7.7 (8/104)
Gender
Women	45.2 (47/104)	51.1 (24/47)	25.5 (12/47)	2.1 (1/47)	14.9 (7/47)	6.4 (3/47)
Age				70
Men	54.8 (57/104)	24.6 (14/57)	24.6 (14/57)	36.8 (21/57)	5.3 (3/57)	8.7 (5/57)
Age
Stage (TNM)
IIA	0.9 (1/104)	—	—	—	10 (1/10)	—
IIIA	2.9 (3/104)	—	11.5 (3/26)	—	—	—
IIIB	5.8 (6/104)	5.3 (2/38)	7.7 (2/26)	9.1 (2/22)	—	—
IV	90.4 (94/104)	94.7 (36/38)	80.8 (21/26)	90.9 (20/22)	90 (9/10)	100 (8/8)

Data are shown as a % (number of patients/total patients). Age is expressed in years as . LAC: lung adenocarcinoma; W: LAC associated with wood smoke exposure; N: LAC patients with no recognizable risk factor; TS: LAC associated with tobacco smoking; PS: LAC associated with passive smoking; TW: LAC associated with tobacco smoking and wood smoke exposure.